hydroxyproline has been researched along with concanavalin a in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askari, FK; Brewer, GJ; Dick, R; Mao, M | 1 |
| Ando, K; Izawa, A; Miyauchi, Y; Sone, S; Suzuki, T; Takemi, N; Tanabe, J; Torii, Y; Tsuchiyama, H | 1 |
| Gong, ZJ; Shi, JZ; Wang, LW; Xu, W | 1 |
| El-Demerdash, E; Elfeky, MG; Fawzy, HM; Gad, AM; Mantawy, EM | 1 |
4 other study(ies) available for hydroxyproline and concanavalin a
| Article | Year |
|---|---|
Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice.
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride Poisoning; Chelating Agents; Concanavalin A; Copper; Cytokines; Hydroxyproline; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Molybdenum | 2004 |
Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects.
Topics: Animals; Collagen; Collagen Type I; Concanavalin A; Cytokines; Disease Progression; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Growth Substances; Hemostasis; Hydroxyproline; Interferon Type I; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Mice; Mice, Inbred BALB C; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-1 | 2007 |
Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Topics: Actins; Animals; Concanavalin A; Down-Regulation; Hydroxyproline; Immunohistochemistry; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred Strains; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Smad3 Protein; Transforming Growth Factor beta1 | 2009 |
Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways.
Topics: Actins; Animals; Biphenyl Compounds; Concanavalin A; Hydroxyproline; Inflammation; Lignans; Liver Cirrhosis; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Survival Analysis; Transforming Growth Factor beta | 2020 |